BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16299569)

  • 21. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
    Lie AK; Kristensen G
    Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and typing of human papillomavirus nucleic acids in biological fluids.
    Coutlée F; Mayrand MH; Roger M; Franco EL
    Public Health Genomics; 2009; 12(5-6):308-18. PubMed ID: 19684443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
    Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natural history of cervical HPV infection: unresolved issues.
    Woodman CB; Collins SI; Young LS
    Nat Rev Cancer; 2007 Jan; 7(1):11-22. PubMed ID: 17186016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus: the burden of infection.
    Wiley D; Masongsong E
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S3-14. PubMed ID: 16729902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.
    Beiner ME; Finch A; Rosen B; Lubinski J; Moller P; Ghadirian P; Lynch HT; Friedman E; Sun P; Narod SA;
    Gynecol Oncol; 2007 Jan; 104(1):7-10. PubMed ID: 16962648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary gynaecological malignancies: advances in screening and treatment.
    Folkins AK; Longacre TA
    Histopathology; 2013 Jan; 62(1):2-30. PubMed ID: 23240667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic errors in oncologic gynecology and ways of their prevention].
    Novikova EG; Antoshechkina ET; Prozorov AS
    Sov Med; 1991; (12):63-6. PubMed ID: 1780788
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular profiling of cervical neoplasia.
    Martin CM; Astbury K; O'Leary JJ
    Expert Rev Mol Diagn; 2006 Mar; 6(2):217-29. PubMed ID: 16512781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM; Bazaldua OV; Vargas L; Reile E
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
    Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New advances in vaccine technology and improved cervical cancer prevention.
    Huh WK; Kendrick JE; Alvarez RD
    Obstet Gynecol; 2007 May; 109(5):1187-92. PubMed ID: 17470604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early diagnosis of gynaecologic and breast cancers].
    Grzybowski W; Powolny M; Pietrzak P; Szafranko K
    Ginekol Pol; 2001 Dec; 72(12A):1465-72. PubMed ID: 11883298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.